Business Description
Whanin Pharm Co Ltd
ISIN : KR7016580003
Compare
Compare
Traded in other countries / regions
016580.Korea IPO Date
1996-07-01Description
Whanin Pharm Co Ltd is a pharmaceutical company. The company develops, manufactures, markets, and sells the therapeutic products. It offers antibiotics, cardiovascular drugs, CNS stimulants, gastrointestinal drugs, multivitamins and other products. The company's products include Antiasthmatics; Antidepressants; Antipsychotics; Anxiolytics and hypnotics; and Antiepileptics.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 101.71 | |||||
| Equity-to-Asset | 0.89 | |||||
| Debt-to-EBITDA | 0.01 | |||||
| Interest Coverage | 1265.83 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 4.73 | |||||
| Beneish M-Score | -2.42 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.3 | |||||
| 3-Year EBITDA Growth Rate | 4.8 | |||||
| 3-Year EPS without NRI Growth Rate | 9.8 | |||||
| 3-Year Book Growth Rate | 6.6 | |||||
| Future 3-5Y Total Revenue Growth Rate | 8.5 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 69.54 | |||||
| 9-Day RSI | 57.42 | |||||
| 14-Day RSI | 50.16 | |||||
| 6-1 Month Momentum % | -17.18 | |||||
| 12-1 Month Momentum % | -17.24 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.54 | |||||
| Quick Ratio | 3.02 | |||||
| Cash Ratio | 1.18 | |||||
| Days Inventory | 141 | |||||
| Days Sales Outstanding | 109.61 | |||||
| Days Payable | 50.28 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.47 | |||||
| Dividend Payout Ratio | 0.17 | |||||
| Forward Dividend Yield % | 2.47 | |||||
| 5-Year Yield-on-Cost % | 2.47 | |||||
| Shareholder Yield % | 2.39 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 38.29 | |||||
| Operating Margin % | 10.74 | |||||
| Net Margin % | 10.87 | |||||
| FCF Margin % | -2.44 | |||||
| ROE % | 7.54 | |||||
| ROA % | 6.67 | |||||
| ROIC % | 7.66 | |||||
| ROC (Joel Greenblatt) % | 13.6 | |||||
| ROCE % | 8.61 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 6.77 | |||||
| Forward PE Ratio | 7.92 | |||||
| PE Ratio without NRI | 6.78 | |||||
| Price-to-Owner-Earnings | 23.44 | |||||
| PEG Ratio | 1.33 | |||||
| PS Ratio | 0.74 | |||||
| PB Ratio | 0.49 | |||||
| Price-to-Tangible-Book | 0.5 | |||||
| Price-to-Operating-Cash-Flow | 5.93 | |||||
| EV-to-EBIT | 4.25 | |||||
| EV-to-EBITDA | 3.4 | |||||
| EV-to-Revenue | 0.53 | |||||
| EV-to-FCF | -21.71 | |||||
| Price-to-Projected-FCF | 0.59 | |||||
| Price-to-DCF (Earnings Based) | 0.54 | |||||
| Price-to-Median-PS-Value | 0.45 | |||||
| Price-to-Graham-Number | 0.39 | |||||
| Price-to-Net-Current-Asset-Value | 1.23 | |||||
| Price-to-Net-Cash | 67.4 | |||||
| Earnings Yield (Greenblatt) % | 23.51 | |||||
| FCF Yield % | -3.31 | |||||
| Forward Rate of Return (Yacktman) % | 3.76 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Whanin Pharm Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 251,728.778 | ||
| EPS (TTM) (â‚©) | 1792 | ||
| Beta | 0.31 | ||
| Volatility % | 16.56 | ||
| 14-Day RSI | 50.16 | ||
| 14-Day ATR (â‚©) | 198.009048 | ||
| 20-Day SMA (â‚©) | 11958.5 | ||
| 12-1 Month Momentum % | -17.24 | ||
| 52-Week Range (â‚©) | 11250 - 15900 | ||
| Shares Outstanding (Mil) | 15.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Whanin Pharm Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Whanin Pharm Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Whanin Pharm Co Ltd Frequently Asked Questions
What is Whanin Pharm Co Ltd(XKRX:016580)'s stock price today?
The current price of XKRX:016580 is â‚©12140.00. The 52 week high of XKRX:016580 is â‚©15900.00 and 52 week low is â‚©11250.00.
When is next earnings date of Whanin Pharm Co Ltd(XKRX:016580)?
The next earnings date of Whanin Pharm Co Ltd(XKRX:016580) is .
Does Whanin Pharm Co Ltd(XKRX:016580) pay dividends? If so, how much?
The Dividend Yield %  of Whanin Pharm Co Ltd(XKRX:016580) is 2.47% (As of Today), Highest Dividend Payout Ratio of Whanin Pharm Co Ltd(XKRX:016580) was 0.24. The lowest was 0.15. And the median was 0.19. The  Forward Dividend Yield % of Whanin Pharm Co Ltd(XKRX:016580) is 2.47%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers